The Procter & Gamble Company (PG) Key Metrics
PG valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $370.12B
- Enterprise value
- $370.11B
- P/E (TTM)
- 24.1 10-yr median 24.5
- Forward P/E
- 21.2
- PEG ratio
- 3.79
- Price / sales
- 4.3 10-yr median 4.5
- Price / book
- 6.5 10-yr median 7.1
- EV / EBITDA
- 15.2 10-yr median 17.7
- Dividend yield
- 2.73% $4.35 a year
- Beta
- 0.38
PG key metrics, FY2017–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsPG valuation Price multiples at each fiscal year-end price.
PG returns How much profit the business earns on the capital it uses.
PG per-share figures Results divided by the shares outstanding at year-end.
PG financial health Debt, liquidity and how easily interest is covered.
PG efficiency & capital use Working capital cycle and where the cash goes.
PG valuation history
PG returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
PG debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
PG cash returned to shareholders
PG price vs earnings per share
PG key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $355.24B | $391.04B | $407.67B | $376.91B | $365.10B | $350.95B | $313.97B | $278.46B | $207.38B | $238.83B |
| Enterprise value | $380.32B | $416.94B | $431.55B | $404.08B | $390.18B | $373.50B | $333.40B | $298.27B | $226.93B | $255.33B |
| P/E ratio | 22.1 | 24.5 | 27.4 | 25.7 | 24.8 | 24.5 | 24.1 | 71.5 | 21.3 | 15.6 |
| Price / sales | 4.1 | 4.6 | 4.9 | 4.6 | 4.6 | 4.6 | 4.4 | 4.1 | 3.1 | 3.7 |
| Price / book | 6.5 | 7.5 | 8.1 | 8.1 | 7.8 | 7.6 | 6.7 | 5.9 | 4.0 | 4.3 |
| Price / free cash flow | 23.5 | 27.8 | 24.7 | 27.3 | 26.9 | 22.5 | 21.9 | 23.4 | 18.6 | 25.5 |
| Price / operating cash flow | 18.2 | 21.9 | 20.5 | 22.4 | 21.8 | 19.1 | 18.0 | 18.3 | 13.9 | 18.7 |
| EV / sales | 4.4 | 4.9 | 5.1 | 4.9 | 4.9 | 4.9 | 4.7 | 4.4 | 3.4 | 3.9 |
| EV / EBITDA | 15.6 | 17.4 | 19.1 | 18.6 | 18.4 | 17.9 | 17.3 | 31.7 | 13.6 | 15.4 |
| EV / free cash flow | 25.1 | 29.7 | 26.1 | 29.3 | 28.8 | 24.0 | 23.3 | 25.1 | 20.4 | 27.3 |
| Earnings yield | 4.5% | 4.1% | 3.6% | 3.9% | 4.0% | 4.1% | 4.1% | 1.4% | 4.7% | 6.4% |
| Free cash flow yield | 4.3% | 3.6% | 4.1% | 3.7% | 3.7% | 4.4% | 4.6% | 4.3% | 5.4% | 3.9% |
| Dividend yield | 2.9% | 2.5% | 2.3% | 2.4% | 2.4% | 2.4% | 2.5% | 2.7% | 3.5% | 3.0% |
| Shareholder yield (dividends + buybacks) | 4.3% | 4.2% | 3.5% | 4.3% | 5.1% | 5.5% | 4.8% | 4.5% | 6.9% | 5.2% |
| Share price at fiscal year-end | $146.64 | $159.32 | $164.92 | $151.74 | $143.79 | $134.93 | $119.57 | $109.65 | $78.06 | $87.15 |
| Per share | ||||||||||
| Revenue per share | $35.93 | $34.34 | $34.00 | $33.02 | $31.58 | $29.26 | $27.02 | $26.65 | $25.16 | $23.74 |
| Earnings per share | $6.62 | $6.51 | $6.02 | $5.90 | $5.81 | $5.50 | $4.96 | $1.53 | $3.67 | $5.59 |
| Operating cash flow per share | $8.07 | $7.26 | $8.03 | $6.78 | $6.59 | $7.06 | $6.63 | $6.00 | $5.60 | $4.65 |
| Free cash flow per share | $6.25 | $5.72 | $6.68 | $5.55 | $5.34 | $5.99 | $5.46 | $4.68 | $4.20 | $3.42 |
| Cash per share | $4.10 | $3.89 | $3.84 | $3.32 | $2.84 | $3.96 | $6.16 | $4.05 | $4.46 | $5.52 |
| Book value per share | $22.42 | $21.19 | $20.34 | $18.83 | $18.35 | $17.83 | $17.72 | $18.58 | $19.68 | $20.14 |
| Tangible book value per share | −$3.47 | −$4.71 | −$4.88 | −$7.11 | −$6.61 | −$6.99 | −$6.54 | −$6.81 | −$6.32 | −$5.00 |
| Dividends per share | $4.22 | $4.02 | $3.77 | $3.62 | $3.45 | $3.18 | $2.97 | $2.95 | $2.75 | $2.64 |
| Capex per share | $1.82 | $1.54 | $1.34 | $1.23 | $1.24 | $1.07 | $1.17 | $1.32 | $1.40 | $1.23 |
| Debt per share | $14.46 | $14.45 | $13.50 | $14.26 | $12.72 | $12.63 | $13.56 | $11.85 | $11.82 | $11.55 |
| Shares outstanding | 2.42B | 2.45B | 2.47B | 2.48B | 2.54B | 2.60B | 2.63B | 2.54B | 2.66B | 2.74B |
| Change in shares outstanding | −1.3% | −0.7% | −0.5% | −2.2% | −2.4% | −0.9% | +3.4% | −4.4% | −3.1% | −3.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 30.2% | 31.2% | 30.7% | 31.4% | 31.7% | 30.8% | 27.8% | 7.8% | 18.1% | 27.2% |
| Return on invested capital (ROIC) | 19.9% | 21.4% | 20.0% | 20.0% | 20.8% | 21.7% | 19.6% | 5.2% | 13.8% | 14.5% |
| Return on assets (ROA) | 12.7% | 12.9% | 12.2% | 12.3% | 12.5% | 11.9% | 11.0% | 3.3% | 8.2% | 12.4% |
| Return on tangible assets | 25.2% | 25.9% | 24.8% | 26.0% | 27.4% | 26.1% | 22.9% | 7.7% | 19.8% | 29.7% |
| Free cash flow margin | 17.4% | 16.7% | 19.7% | 16.8% | 16.9% | 20.5% | 20.2% | 17.6% | 16.7% | 14.4% |
| Income quality (OCF / net income) | 1.22 | 1.12 | 1.33 | 1.15 | 1.13 | 1.28 | 1.34 | 3.91 | 1.52 | 0.83 |
| Financial health | ||||||||||
| Total debt | $35.03B | $35.46B | $33.37B | $35.42B | $32.29B | $32.84B | $35.61B | $30.10B | $31.39B | $31.64B |
| Cash & short-term investments | $9.94B | $9.56B | $9.48B | $8.25B | $7.21B | $10.29B | $16.18B | $10.29B | $11.85B | $15.14B |
| Net debt | $25.08B | $25.91B | $23.89B | $27.18B | $25.08B | $22.55B | $19.43B | $19.81B | $19.54B | $16.51B |
| Debt / equity | 0.64 | 0.68 | 0.66 | 0.76 | 0.69 | 0.71 | 0.77 | 0.64 | 0.60 | 0.57 |
| Debt / assets | 0.28 | 0.28 | 0.27 | 0.29 | 0.28 | 0.28 | 0.30 | 0.26 | 0.27 | 0.26 |
| Net debt / EBITDA | 1.03 | 1.08 | 1.06 | 1.25 | 1.18 | 1.08 | 1.01 | 2.11 | 1.17 | 1.00 |
| Current ratio | 0.68 | 0.70 | 0.73 | 0.63 | 0.65 | 0.70 | 0.85 | 0.75 | 0.83 | 0.88 |
| Quick ratio | 0.47 | 0.49 | 0.53 | 0.44 | 0.45 | 0.52 | 0.68 | 0.58 | 0.66 | 0.72 |
| Interest coverage | 22.5 | 22.5 | 20.0 | 24.0 | 40.6 | 35.8 | 33.8 | 10.8 | 26.4 | 29.6 |
| Working capital | −$12.49B | −$10.67B | −$8.92B | −$13.11B | −$11.43B | −$10.04B | −$4.99B | −$7.54B | −$4.92B | −$3.72B |
| Invested capital | $79.39B | $77.92B | $74.17B | $73.95B | $71.67B | $68.93B | $65.95B | $67.01B | $71.84B | $71.69B |
| Tangible asset value | −$8.41B | −$11.28B | −$11.79B | −$17.38B | −$16.52B | −$17.91B | −$16.82B | −$16.91B | −$16.19B | −$13.11B |
| Net current asset value | −$46.00B | −$47.55B | −$47.10B | −$51.12B | −$48.70B | −$49.56B | −$45.84B | −$45.04B | −$42.11B | −$38.13B |
| Graham number | $57.80 | $55.71 | $52.49 | $50.00 | $48.96 | $46.97 | $44.47 | $25.33 | $40.32 | $50.34 |
| Graham net-net per share | −$22.14 | −$22.40 | −$21.94 | −$23.30 | −$21.98 | −$21.46 | −$19.71 | −$20.09 | −$17.95 | −$15.96 |
| Capital allocation | ||||||||||
| Dividends paid | $10.23B | $9.87B | $9.31B | $9.00B | $8.77B | $8.26B | $7.79B | $7.50B | $7.31B | $7.24B |
| Share buybacks (net) | $5.03B | $6.50B | $5.01B | $7.35B | $10.00B | $11.01B | $7.41B | $5.00B | $7.00B | $5.20B |
| Dividend payout ratio | 63.8% | 61.8% | 62.6% | 61.4% | 59.5% | 57.8% | 59.8% | 192.4% | 75.0% | 47.2% |
| Dividends + buybacks / free cash flow | 100.7% | 116.6% | 86.6% | 118.6% | 138.4% | 123.7% | 106.0% | 105.1% | 128.4% | 132.8% |
| Capex / revenue | 5.1% | 4.5% | 4.0% | 3.7% | 3.9% | 3.7% | 4.3% | 4.9% | 5.6% | 5.2% |
| Capex / operating cash flow | 22.5% | 21.2% | 16.7% | 18.2% | 18.9% | 15.2% | 17.7% | 22.0% | 25.0% | 26.5% |
| Capex / depreciation | 1.40 | 1.33 | 1.15 | 1.13 | 1.12 | 1.02 | 1.02 | 1.19 | 1.31 | 1.20 |
| Stock-based compensation / revenue | 0.6% | 0.6% | 0.7% | 0.7% | 0.7% | 0.7% | 0.8% | 0.8% | 0.6% | 0.6% |
| R&D / revenue | — | 2.5% | 2.4% | 2.4% | 2.5% | 2.5% | 2.5% | 2.8% | 2.9% | 2.9% |
| SG&A / revenue | 27.5% | 14.8% | 26.8% | 16.0% | 14.6% | 16.8% | 17.3% | 27.6% | 17.4% | 17.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 25.7 | 26.6 | 25.2 | 23.6 | 22.5 | 21.3 | 23.5 | 26.0 | 25.3 | 25.2 |
| Days of inventory on hand | 66.2 | 64.6 | 62.9 | 59.7 | 55.9 | 56.5 | 54.4 | 51.2 | 49.6 | 52.2 |
| Days payables outstanding | 132.7 | 135.6 | 133.9 | 125.8 | 123.8 | 126.8 | 120.8 | 113.4 | 105.9 | 106.0 |
| Cash conversion cycle (days) | -40.9 | -44.4 | -45.8 | -42.5 | -45.5 | -49.0 | -42.9 | -36.2 | -30.9 | -28.6 |
| Receivables turnover | 14.22 | 13.70 | 14.50 | 15.45 | 16.25 | 17.10 | 15.54 | 14.05 | 14.40 | 14.51 |
| Payables turnover | 2.75 | 2.69 | 2.73 | 2.90 | 2.95 | 2.88 | 3.02 | 3.22 | 3.45 | 3.44 |
| Inventory turnover | 5.52 | 5.65 | 5.80 | 6.11 | 6.53 | 6.46 | 6.70 | 7.13 | 7.36 | 6.99 |
| Asset turnover | 0.69 | 0.68 | 0.69 | 0.69 | 0.68 | 0.63 | 0.60 | 0.58 | 0.56 | 0.53 |
| Average receivables | $6.12B | $6.15B | $5.79B | $5.31B | $4.93B | $4.45B | $4.56B | $4.82B | $4.64B | $4.48B |
| Average payables | $15.77B | $15.30B | $14.98B | $14.74B | $14.30B | $12.90B | $11.67B | $10.80B | $9.99B | $9.48B |
| Average inventory | $7.86B | $7.28B | $7.04B | $7.00B | $6.45B | $5.74B | $5.26B | $4.88B | $4.68B | $4.67B |
| Intangibles / total assets | 49.6% | 50.8% | 51.0% | 53.3% | 54.1% | 54.1% | 52.8% | 56.0% | 58.4% | 57.2% |
Computed from PG's annual financial statements (latest annual report filed August 4, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
PG valuation and financial ratios
At the end of fiscal 2026 (June 30, 2026), Procter & Gamble traded at 22.1 times earnings, against a 10-year median of 24.5. Based on the latest twelve months, the trailing P/E is 24.1 and the forward P/E is 21.2. Procter & Gamble earned a return on equity of 30.2% and a return on invested capital of 19.9% in fiscal 2026. It ended the year with $35.0 billion of debt and $9.9 billion in cash and short-term investments, net debt of $25.1 billion. It returned $15.3 billion to shareholders: $10.2 billion in dividends and $5.0 billion in share buybacks, 101% of free cash flow. The share count fell 11.6% from 2.74B to 2.42B over 9 years.
See the PG income statement, the PG chart for price history, or the PG stock overview for the latest quote and news.
PG key metrics FAQ
What is Procter & Gamble's P/E ratio?
Procter & Gamble's trailing P/E ratio is 24.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 21.2. At the end of fiscal 2026 it was 22.1, compared with a 10-year median of 24.5.
What is Procter & Gamble's EV/EBITDA?
Procter & Gamble's enterprise value was 15.6 times EBITDA at the end of fiscal 2026 (enterprise value $380.3 billion, EBITDA $24.4 billion); the current EV/EBITDA is 15.2.
What is Procter & Gamble's return on equity?
Procter & Gamble's return on equity (ROE) was 30.2% in fiscal 2026: net income of $16.0 billion on average shareholders' equity of $53.2 billion.
What is Procter & Gamble's ROIC?
Procter & Gamble's return on invested capital was 19.9% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Procter & Gamble have?
Procter & Gamble had total debt of $35.0 billion at the end of fiscal 2026, a debt-to-equity ratio of 0.64 and $25.1 billion of net debt (1.03 times EBITDA).
What is Procter & Gamble's dividend yield?
Procter & Gamble's forward dividend yield is 2.73%. Procter & Gamble paid $10.2 billion in dividends in fiscal 2026 ($4.22 per share), a payout ratio of 63.8%.
Does Procter & Gamble buy back its shares?
Yes. Procter & Gamble spent $5.0 billion on net share repurchases in fiscal 2026 Shares outstanding changed −1.3% over the year, to 2.42B..
What is Procter & Gamble's free cash flow yield?
Procter & Gamble generated $15.1 billion of free cash flow in fiscal 2026, a free cash flow yield of 4.3% on its market value at year-end ($355.2 billion).
What is Procter & Gamble's current ratio?
Procter & Gamble's current ratio was 0.68 at the end of fiscal 2026: current assets were 0.68 times current liabilities.